Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D.
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.
PLoS ONE. 2009;4(2):e4569. Epub 2009 Feb 24.[PubMed]

Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC.
Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
Am J Trop Med Hyg. 2009 Apr;80(4):523-7.[PubMed]

Mmbando BP, Segeja MD, Msangeni HA, Sembuche SH, Ishengoma DS, Seth MD, Francis F, Rutta AS, Kamugisha ML, Lemnge MM.
Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania.
Malar J. 2009 Jul 18;8:165. [PubMed]

Ishengoma DR, Rwegoshora RT, Mdira KY, Kamugisha ML, Anga EO, Bygbjerg IC, Rønn AM, Magesa SM.
Health laboratories in the Tanga region of Tanzania: the quality of diagnostic services for malaria and other communicable diseases.
Ann Trop Med Parasitol. 2009 Jul;103(5):441-53.[PubMed]

Lusingu JP, Gesase S, Msham S, Francis F, Lemnge M, Seth M, Sembuche S, Rutta A, Minja D, Segeja MD, Bosomprah S, Cousens S, Noor R, Chilengi R, Druilhe P.
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.
Malar J. 2009 Jul 17;8:163.[PubMed]

Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, Sisay-Joof F, Usen S, Auburn S, Bumpstead SJ, Campino S, Coffey A, Dunham A, Fry AE, Green A, Gwilliam R, Hunt SE, Inouye M, Jeffreys AE, Mendy A, Palotie A, Potter S, Ragoussis J, Rogers J, Rowlands K, Somaskantharajah E, Whittaker P, Widden C, Donnelly P, Howie B, Marchini J, Morris A, Sanjoaquin M, Achidi EA, Agbenyega T, Allen A, Amodu O, Corran P, Djimde A, Dolo A, Doumbo OK, Drakeley C, Dunstan S, Evans J, Farrar J, Fernando D, Hien TT, Horstmann RD, Ibrahim M, Karunaweera N, Kokwaro G, Koram KA, Lemnge M, Makani J, Marsh K, Michon P, Modiano D, Molyneux ME, Mueller I, Parker M, Peshu N, Plowe CV, Puijalon O, Reeder J, Reyburn H, Riley EM, Sakuntabhai A, Singhasivanon P, Sirima S, Tall A, Taylor TE, Thera M, Troye-Blomberg M, Williams TN, Wilson M, Kwiatkowski DP; Wellcome Trust Case Control Consortium; Malaria Genomic Epidemiology Network.
Genome-wide and fine-resolution association analysis of malaria in West Africa.
Nat Genet. 2009 May 24. [Epub ahead of print] [PubMed]

Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C.
Rapid assessment of malaria transmission using age-specific sero-conversion rates.
PLoS One. 2009 Jun 29;4(6):e6083.[Pubmed]

Haissman JM, Vestergaard LS, Sembuche S, Erikstrup C, Mmbando B, Mtullu S, Lemnge MM, Gerstoft J, Ullum H.
Plasma Cytokine Levels in Tanzanian HIV-1-Infected Adults and the Effect of Antiretroviral Treatment.
J Acquir Immune Defic Syndr. 2009 Sep 10[Pubmed]


Cham GK, Turner L, Lusingu J, Vestergaard L, Mmbando BP, Kurtis JD, Jensen AT, Salanti A, Lavstsen T, Theander TG.
Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains.
J Immunol. 2009 Sep 1;183(5):3356-63. Epub 2009 Aug 12.[Pubmed]


Cairns M, Gosling R, Gesase S, Mosha J, Greenwood B, Chandramohan D.
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.
Trans R Soc Trop Med Hyg. 2009 Jul 10[Pubmed]

Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D.
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Lancet. 2009 Sep 16[Pubmed]